Company CytRx Corporation Nasdaq
Equities
US2328283013
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 22-01-09 |
John Caloz
DFI | Director of Finance/CFO | 72 | 07-09-30 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Felix Kratz
PRN | Corporate Officer/Principal | - | 14-03-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 21-07-28 |
Cary Claiborne
BRD | Director/Board Member | 64 | 22-07-26 |
Joel Caldwell
BRD | Director/Board Member | 69 | 17-07-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 495,092 | 492,306 ( 99.44 %) | 0 | 99.44 % |
Company contact information
LadRx Corp.
11726 San Vicente Boulevard Suite 650
90049, Los Angeles
+310 826 5648
http://www.ladrxcorp.comSector
1st Jan change | Capi. | |
---|---|---|
+1.31% | 43.84B | |
+6.40% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.85% | 25.53B | |
-23.99% | 18.18B | |
-3.33% | 12.29B | |
+26.06% | 12.29B | |
+7.18% | 11.15B |
- Stock Market
- Equities
- LADX Stock
- Stock
- Company CytRx Corporation